2024KDIGO慢性肾脏病评估和管理指南要点解读  

Key points interpretation of 2024 Kidney Disease:Improving Global Outcomes(KDIGO)clinical practice guideline for the evaluation and management of chronic kidney disease

作　　者：张莲[1] 张娟[1] 查冬青[1] 高苹[1] 吴小燕[1] ZHANG Lian;ZHANG Juan;ZHA Dong-qing;Gao Ping;Wu Xiao-yan(Department of Nephropathy,Zhongnan Hospital of Wuhan University,Hubei Wuhan 430071,China)

机构地区：[1]武汉大学中南医院肾病内科,湖北武汉430071

出　　处：《内科急危重症杂志》2024年第4期297-302,共6页Journal of Critical Care In Internal Medicine

摘　　要：2012年改善全球肾脏病预后组织(KDIGO)发布了慢性肾脏病(CKD)评估和管理指南,为广大临床工作者对CKD的诊治提供了详尽的指导意见。近年来CKD领域大量循证医学证据不断出现,工作组时隔12年后对该指南做出更新,主要涉及CKD评估、CKD患者的风险评估、延缓CKD进展及其并发症的管理、CKD的医疗管理和药物管理,以及CKD护理的最佳模式等方面。本文就该指南的要点进行解读。The Kidney Disease:Improving Global Outcomes(KDIGO)Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease was originally published in 2012,which assists practitioners in clinical diagnosis,prevention and treatment of chronic kidney disease(CKD).In recent years,a large number of evidence-based medical evidence has been emerging in the field of CKD.After 12 years,the work group has updated the guidelines,mainly involving the evaluation of CKD,risk assessment in people with CKD,management to delay CKD progression and manage its complications,medical management and drug stewardship in CKD,and optimal models of CKD care.This article interprets the key points of the 2024 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD.

关 键 词：慢性肾脏病 评估 管理 改善全球肾脏病预后组织 指南 

分 类 号：R692[医药卫生—泌尿科学]